Literature DB >> 10464167

Virus-induced non-specific signals cause cell cycle progression of primed CD8(+) T cells but do not induce cell differentiation.

S O Andreasen1, J P Christensen, O Marker, A R Thomsen.   

Abstract

In this report the significance of virus-induced non-specific T cell activation was re-evaluated using transgenic mice in which about half of the CD8(+) T cells expressed a TCR specific for amino acids 33-41 of lymphocytic choriomeningitis virus glycoprotein I. This allowed tracing of cells with known specificity and priming history in an environment also containing a normal heterogeneous CD8(+) population which served as an intrinsic control. Three parameters of T cell activation were analyzed: cell cycle progression, phenotypic conversion and cytolytic activity. Following injection of the IFN inducer poly(I:C), proliferation of memory (CD44(hi)) CD8(+) T cells but no phenotypic or functional activation was observed. Following injection of an unrelated virus [vesicular stomatitis virus (VSV)], naive TCR transgenic cells did not become significantly activated with respect to any of the parameters investigated. In contrast, memory TCR transgenic cells were found to proliferate extensively early after VSV infection (day 0-3), whereas limited proliferation was observed later (day 3-6) when proliferation of non-transgenic CD8(+) T cells is maximal. This aborted response did not result from anergy to TCR stimulation, as memory TCR transgenic cells proliferated vigorously upon stimulation with their nominal peptide. Despite the massive proliferation of memory cells observed early after VSV infection, no phenotypic or functional activation was observed. Together these findings indicate that both non-specific and antigen-specific signals contribute to the initial virus-induced proliferation of CD8(+) T cells, but for further proliferation and differentiation to take place, TCR-ligand interaction is required. The implications for maintenance of T cell memory is discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10464167     DOI: 10.1093/intimm/11.9.1463

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  8 in total

1.  Phenotypic and functional profiling of malaria-induced CD8 and CD4 T cells during blood-stage infection with Plasmodium yoelii.

Authors:  Anmol Chandele; Paushali Mukerjee; Gobardhan Das; Rafi Ahmed; Virander S Chauhan
Journal:  Immunology       Date:  2010-10-29       Impact factor: 7.397

2.  Perforin-deficient CD8+ T cells mediate fatal lymphocytic choriomeningitis despite impaired cytokine production.

Authors:  Pernille Storm; Christina Bartholdy; Maria Rathman Sørensen; Jan Pravsgaard Christensen; Allan Randrup Thomsen
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

Review 3.  The role of bystander T cells in CNS pathology and pathogen clearance.

Authors:  Dorian B McGavern
Journal:  Crit Rev Immunol       Date:  2005       Impact factor: 2.214

4.  Persistent virus infection despite chronic cytotoxic T-lymphocyte activation in gamma interferon-deficient mice infected with lymphocytic choriomeningitis virus.

Authors:  C Bartholdy; J P Christensen; D Wodarz; A R Thomsen
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

5.  Quantitating the magnitude of the lymphocytic choriomeningitis virus-specific CD8 T-cell response: it is even bigger than we thought.

Authors:  David Masopust; Kaja Murali-Krishna; Rafi Ahmed
Journal:  J Virol       Date:  2006-12-06       Impact factor: 5.103

6.  CCR5 and CXCR3 are dispensable for liver infiltration, but CCR5 protects against virus-induced T-cell-mediated hepatic steatosis.

Authors:  P J Holst; C Orskov; K Qvortrup; J P Christensen; A R Thomsen
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

7.  The virus-encoded chemokine vMIP-II inhibits virus-induced Tc1-driven inflammation.

Authors:  Morten Lindow; Anneline Nansen; Christina Bartholdy; Annette Stryhn; Nils J V Hansen; Thomas P Boesen; Timothy N C Wells; Thue W Schwartz; Allan R Thomsen
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

8.  Combination immunotherapy with anti-PD-L1 antibody and depletion of regulatory T cells during acute viral infections results in improved virus control but lethal immunopathology.

Authors:  Paul David; Malgorzata Drabczyk-Pluta; Eva Pastille; Torben Knuschke; Tanja Werner; Nadine Honke; Dominik A Megger; Ilseyar Akhmetzyanova; Namir Shaabani; Annette Eyking-Singer; Elke Cario; Olivia Kershaw; Achim D Gruber; Matthias Tenbusch; Kirsten K Dietze; Mirko Trilling; Jia Liu; Dirk Schadendorf; Hendrik Streeck; Karl S Lang; Youhua Xie; Lisa Zimmer; Barbara Sitek; Annette Paschen; Astrid M Westendorf; Ulf Dittmer; Gennadiy Zelinskyy
Journal:  PLoS Pathog       Date:  2020-03-30       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.